InvestSMART

Medigard Limited (ASX: MGZ) - Announcements

DELISTED - Current share price for MGZ : $0.020

ASX company news and announcements for Medigard Limited (MGZ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medigard Limited (MGZ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medigard Limited (MGZ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medigard Limited (MGZ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Half Yearly Report and Accounts 29 Feb 2012 5:57PM $0.016 $0.020 risen by 25%
- Appendix 4C - quarterly 30 Jan 2012 4:26PM $0.018 $0.020 risen by 11.11%
- Appendix 4C - quarterly 25 Oct 2011 2:56PM $0.015 $0.020 risen by 33.33%
- Preliminary Final Report 31 Aug 2011 2:52PM $0.026 $0.020 fallen by 23.08%
- Appendix 4C - quarterly 29 Jul 2011 7:30PM $0.025 $0.020 fallen by 20%
- Appendix 4C - 31 March 2011 29 Apr 2011 10:03AM $0.040 $0.020 fallen by 50%
- Notice of Resignation CEO and Company Secretary 24 Feb 2011 4:29PM $0.045 $0.020 fallen by 55.56%
- Half Yearly Report and Accounts 24 Feb 2011 3:53PM $0.031 $0.020 fallen by 35.48%
- Grant of Japanese Patent (BCD) and IPRP (1mL Syringe) 1 Feb 2011 4:25PM $0.050 $0.020 fallen by 60%
- Appendix 4C - quarterly 28 Jan 2011 2:21PM $0.040 $0.020 fallen by 50%
- Appendix 4C - quarterly 28 Oct 2010 2:24PM $0.051 $0.020 fallen by 60.78%
- Grant of Patent in South Africa 21 Sep 2010 1:24PM $0.056 $0.020 fallen by 64.29%
- Preliminary Final Report 31 Aug 2010 2:42PM $0.045 $0.020 fallen by 55.56%
- Market Announcement 5 Aug 2010 10:06AM $0.090 $0.020 fallen by 77.78%
- Appendix 4C - quarterly 29 Jul 2010 3:18PM $0.090 $0.020 fallen by 77.78%
- Prospectus 27 Jul 2010 9:53AM $0.120 $0.020 fallen by 83.33%
- Renounceable Issue 27 Jul 2010 9:48AM $0.120 $0.020 fallen by 83.33%
- Signing of US Manufacturing and Distribution Agreements 26 May 2010 4:57PM $0.120 $0.020 fallen by 83.33%
- Trading Halt 25 May 2010 2:33PM $0.120 $0.020 fallen by 83.33%
- Appendix 4C - quarterly 16 Apr 2010 10:16AM $0.105 $0.020 fallen by 80.95%
- Clinical Trial Results USA - Medigard Syringe 6 Apr 2010 11:41AM $0.120 $0.020 fallen by 83.33%
- Marketing and Product Evaluation USA 24 Mar 2010 5:48PM $0.082 $0.020 fallen by 75.61%
- Half Yearly Report and Accounts 26 Feb 2010 2:21PM $0.082 $0.020 fallen by 75.61%
- Appendix 4C - quarterly 25 Jan 2010 4:33PM $0.100 $0.020 fallen by 80%
- Medigard Signs US Manufacturer 11 Dec 2009 6:06PM $0.130 $0.020 fallen by 84.62%

151 - 175 of 213 results

Page 7 of 9

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.